WINT · Windtree Therapeutics Inc /De/
$0.00
+0.00 (+0.00%)
At close · Jul 29
Going-concern doubt
— flagged Nov 19, 2025
Substantial doubt about the company's ability to continue as a going concern.
“We do *not* have sufficient cash and cash equivalents as of the date of this Quarterly Report on Form *10*-Q to support our operations for at least the *12* months following the date that the financial statements are issued. These conditions raise substantial doubt about our ability to continue as a going concern. To alleviate the conditions that raise substantial doubt about our ability to continue as a going concern, management plans to secure additional capital, potentially through a combination of public or private securities offerings, convertible debt financings, and/or strategic transactions, including potential licensing arrangements, alliances, and drug product collaborations focused on specified geographic markets; however, *none* of these alternatives are committed at this time.”View the 10-Q filed Nov 19, 2025
Market Cap
$337,087
Shares
33.71M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$198K
-88.9%
FY2019
Net Income
-$1.79M
+91.2%
FY2024
Gross Margin
5.88%
+0.1pp
FY2015
Operating Margin
-12572.22%
-11666.5pp
FY2019
Diluted EPS
-$1,044,900.00
+67.9%
FY2018
Operating Cash Flow
-$15.4M
-14.6%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $198K | $1.79M | $1.49M | $2.04M | $987K | $2.84M | $388K | $195K | — | — | |
| $0 | — | — | — | — | — | — | — | — | — | $929K | $2.67M | $517K | $0 | $0 | — | |
| $871K | — | — | — | — | — | — | — | — | — | $58K | $164K | -$129K | $195K | — | — | |
| — | — | — | — | — | — | — | — | — | — | 5.88% | 5.78% | -33.25% | 100% | — | — | |
| $8.54M | $16.28M | $8.34M | $11.1M | $17.79M | $15.37M | $12.69M | $10.56M | $17.38M | $31.71M | $28.89M | $26.69M | $27.66M | $21.57M | $17.23M | $17.14M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $7.86M | $8.39M | |
| $8.41M | $8.74M | $9.2M | $10.79M | $14.47M | $14.94M | $12.4M | $7.42M | $6.66M | $8.37M | $11M | $16.73M | $16.72M | $16.44M | $7.86M | $8.39M | |
| — | — | — | — | — | — | — | — | $192K | $255K | $712K | $818K | $707K | $1.15M | $1.23M | $1.55M | |
| — | — | — | — | — | — | — | — | — | — | $2.9M | — | — | — | — | — | |
| $33.5M | $26.14M | $20.6M | $41.33M | $77.28M | $30.32M | $25.09M | $17.98M | $24.03M | $40.08M | $40.82M | $46.09M | $44.9M | $38.01M | $25.09M | $25.53M | |
| -$33.5M | -$26.14M | -$20.6M | -$41.33M | -$77.28M | -$30.32M | -$24.89M | -$16.2M | -$22.55M | -$38.04M | -$39.83M | -$43.26M | -$44.51M | -$37.82M | -$24.51M | -$25.53M | |
| — | — | — | — | — | — | -12572.22% | -905.76% | -1518.38% | -1862.68% | -4035.87% | -1525.86% | -11471.13% | -19394.36% | — | — | |
| — | — | — | — | — | — | — | — | -$22.36M | -$37.78M | -$39.12M | -$42.44M | -$43.8M | -$36.67M | -$23.28M | -$23.98M | |
| $488K | $235K | $50K | $53K | $114K | $125K | $495K | $1.41M | $1.86M | $2.52M | $4.58M | — | — | — | — | — | |
| $971K | $70K | $325K | $109K | $91K | $122K | $153K | $15K | $12K | $18K | $4000 | — | — | — | — | — | |
| -$10.01M | $24.35M | $306K | $758K | -$343K | -$2.25M | -$2.58M | -$4.34M | $4.1M | -$1.68M | -$16.19M | -$4.59M | -$1.47M | -$51K | -$13K | -$69K | |
| -$43.5M | -$1.79M | -$20.29M | -$40.58M | -$77.62M | -$32.57M | — | — | — | — | — | — | — | — | — | — | |
| -$3.51M | -$6000 | $0 | -$1.37M | -$9.99M | $0 | — | — | — | — | $0 | $0 | $0 | $0 | — | — | |
| -$39.99M | -$1.79M | -$20.29M | -$39.21M | -$67.64M | -$32.57M | -$27.48M | -$20.53M | -$18.45M | -$39.49M | -$55.17M | -$44.06M | -$45.22M | -$37.32M | -$20.97M | -$19.18M | |
| — | — | — | — | — | — | -13876.26% | -1148.38% | -1242.15% | -1933.89% | -5589.67% | -1554.07% | -11653.35% | -19135.9% | — | — | |
| -$48.83M | -$5.49M | -$20.29M | — | — | — | -$27.48M | -$34.76M | -$24.82M | -$39.49M | — | — | — | — | — | — | |
| USD/shares | — | -$104.35 | -$4,718.84 | -$56,007.00 | -$122,976.00 | — | — | -$1,044,900.00 | -$3,258,900.00 | -$639,900.00 | -$1,077,300.00 | -$982,800.00 | -$110,700.00 | -$128,250.00 | — | — |
| USD/shares | — | — | — | — | — | — | — | -$1,044,900.00 | -$3,258,900.00 | -$639,900.00 | -$1,077,300.00 | -$1,058,400.00 | -$110,700.00 | -$128,250.00 | — | — |
| shares | — | 52.58M | 4.3M | 700 | 550 | 347.8667 | 242.8444 | 33.2815 | 7.6148 | 61.6889 | 51.6074 | 45.0222 | 409.3185 | 291.8222 | 0.1679 | — |
| shares | — | — | — | — | 550.2222 | 347.8667 | 242.8444 | 33.2815 | 7.6148 | 61.6889 | 51.6074 | 45.5185 | 409.3185 | 291.8222 | 167.8519 | 85.9407 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2024: $657K in dividends.